United States — Food and Drug Administration & Israel
8 shared events · Importance 3 · Last updated May 18, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration approved Eli Lilly and Company's weight loss pill, Foundayo, impacting the pharmaceutical market.
Israel: Israel is seeking talks with Lebanon, contributing to easing worries over the Middle East conflict and positively influencing market sentiment.
Apr 01, 2026 · 14 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
Israel: Israel is engaged in military exchanges with Iran and Hezbollah, contributing to regional instability and affecting global markets.
May 18, 2026 · 243 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) approval is a critical milestone for Jyong Biotech's lead drug candidates, as it enables market access and sets a precedent for global regulatory pathways.
Israel: Israel is identified as a global market where FDA approval could accelerate regulatory pathways for Jyong Biotech's products.
May 29, 2026 · 7 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration accepted the Biologics License Application for imlifidase in February 2026, indicating potential future market expansion for the drug in the US.
Israel: Imlifidase is approved in Israel, further expanding its international market reach.
May 27, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Israel interact across events, view sentiment trends, and discover connected entities.
Open Dashboard